Tenax Therapeutics (TENX) Assets (2011 - 2026)

Tenax Therapeutics (TENX) has 15 years of Assets data on file, last reported at $123.2 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 9.92% year-over-year to $123.2 million; the trailing twelve-month figure through Mar 2026 stood at $123.2 million (up 9.92% YoY), and the FY2025 full-year result was $104.2 million, up 7.8% from the prior year.
• Assets improved to $123.2 million in Q1 2026, from $104.2 million in the prior quarter.
• In the past five years, Assets ranged from a high of $123.2 million in Q1 2026 to a low of $3.4 million in Q4 2022.
• A 5-year average of $49.6 million and a median of $14.5 million in 2024 frame the typical range for Assets.
• Across the five-year window, Assets plunged 46.82% in 2022 and jumped 897.06% in 2025, its largest moves.
• Tracing TENX's Assets over 5 years: stood at $3.4 million in 2022, then soared by 243.2% to $11.7 million in 2023, then surged by 727.44% to $96.7 million in 2024, then rose by 7.8% to $104.2 million in 2025, then increased by 18.18% to $123.2 million in 2026.
• Business Quant data shows TENX's Assets at $123.2 million in Q1 2026, $104.2 million in Q4 2025, and $102.8 million in Q3 2025.